|
Post by mnkdorbust on Jan 4, 2017 14:03:39 GMT -5
based on public filing you can see that Stuart Tross had 25,671 shares of Amgen worth today about $3,914,827. you don't walk away from a good company to take a risk or flyer on a company that is on the brink of bankruptcy. So what is up other than speculation? www.nasdaq.com/quotes/insiders/tross-stuart-a-918546Well if i had pretty much 4 million in just my work stock (assuming he has at least that much in other forms of retirement) I'd hit the cash out button and get out of the rat race to a life with more sand and turquoise waters
|
|
|
Post by dreamboatcruise on Jan 4, 2017 14:12:18 GMT -5
Will Amgen acquire MannKind soon? WOW! My initial thought exactly. For all of you much smarter than I, your thoughts? I doubt you could find much evidence in historical data that 2 management level people moving from the same big company to a small company, unless there is some investment involved, is a predictor of future acquisition. Caveat... I have never tried such analysis and am sure it would take a great deal of effort to collect the data. Non scientific opinion is based on decades of investing, following companies and being within the entrepreneurial community. I don't claim that makes me smart. I do suspect that having a board member that is a current executive of a large company (especially a known acquisitive one) would statistically increase likelihood of a future acquisition.
|
|
|
Post by kball on Jan 4, 2017 14:12:46 GMT -5
thats fancy for a tech company with boatloads of $$$ and high share price like FB, google and other tech companies. For mannkind, its still vp of human resources. reading on stock twits - some one commented we need a chief patients officer.. lol and I agree It's not an officer postion, but nonetheless... • MannKind Corporation is currently seeking a Patient Advocate to support the company’s patient advocacy program by providing resources to patients. rew12.ultipro.com/MAN1011/JobBoard/JobDetails.aspx?__ID=*FF55BEE20CE43E33Like SportsRancho isn't already on this. Go get em Sports
|
|
|
Post by dreamboatcruise on Jan 4, 2017 14:20:25 GMT -5
Which act of spinning are you referring to... acting like MNKD can never achieve it, or acting like mentioning it means it is inevitable. It might mean it's inevitable. And I truly believe it is..Lets see here the biggest reason that Diabetics are not staying on or getting Afrezza is because of cost. Well other countries may cover Afrezza with there health benefits the same as any other insulin so Afrezza may succeed better in them countries.. Well, if we couch inevitable with one might and 2 mays... I'm willing to sign on. One can't argue with possible inevitability, other than perhaps grammatically Actually, I'm a firm believer in "eventual" Afrezza success... just less certain how quickly it will come relative to dilution or insolvency. I'm hopeful that many of us will still make money on our long held investments... though hesitant to encourage friends/family to jump in at this point as I did in the past.
|
|
|
Post by chuck on Jan 4, 2017 14:25:46 GMT -5
MannKind Announces Key Addition to Its Executive Management Ranks VALENCIA, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced that Stuart A. Tross, Ph.D., has joined the company as its Chief People Officer, with responsibilities for Human Resources, Information Technology and West Coast Facilities. Dr. Tross will be integral in accelerating the company's development into a world-class, global biopharmaceutical company centered on the value of its human capital. He will be reporting to Matthew Pfeffer, Chief Executive Officer, and will serve on MannKind's executive leadership team. Just glad they chose him over his less qualified brother Alba Nominating this for post of the year award.
|
|
dang
Newbie
Posts: 20
|
Post by dang on Jan 4, 2017 14:28:04 GMT -5
Actually, I'm a firm believer in "eventual" Afrezza success... just less certain how quickly it will come relative to dilution or insolvency. I'm hopeful that many of us will still make money on our long held investments... though hesitant to encourage friends/family to jump in at this point as I did in the past. This is exactly how I feel. I'm REALLY LONG on MNKD and its because I believe in it. I just sold some old stocks not going anywhere and put it all on MNKD. "Extra money" so to speak. Now that I'm all in its okay for MNKD to go up now. LOL
|
|
|
Post by silentknight on Jan 4, 2017 14:36:08 GMT -5
Once again, people jump into the deep end of the speculation pool in believing that Amgen is somehow magically now going to acquire MNKD because two former officers now work for the company. His reasons for joining the company are between him and MNKD. It could range from him actually believing that Afrezza is the future and he honestly want's to work towards developing a company and product that could have a future, or he might have really messed up at Amgen somehow and was about to get his walking papers and jumped ship before they fired him. It might be somewhere in between but you'd have to ask him yourself to find out, but I seriously doubt it has anything to do with an acquisition. What I believe would be the last possibility is that he's been planted there by Amgen in some elaborate plot to mask secret, black ops plans to subtly acquire a seriously struggling biotech by periodically sending officers over, under the auspices of being a legitimate MNKD employee mind you, to initiate a take over or transition after a buy out takes place. If Amgen wanted to buy MNKD they could do so today with a resonable offer and send Mr. Tross over as an Amgen employee to do it immediately if he really was there for Amgen all along. Would this mean Mike is involved too and has been a double agent this whole time? ? That crafy devil.... A+ for creativity but no.
|
|
|
Post by kc on Jan 4, 2017 14:47:10 GMT -5
based on public filing you can see that Stuart Tross had 25,671 shares of Amgen worth today about $3,914,827. you don't walk away from a good company to take a risk or flyer on a company that is on the brink of bankruptcy. So what is up other than speculation? www.nasdaq.com/quotes/insiders/tross-stuart-a-918546Well if i had pretty much 4 million in just my work stock (assuming he has at least that much in other forms of retirement) I'd hit the cash out button and get out of the rat race to a life with more sand and turquoise waters Being that Stuart is in his mid-50s I would guess he is not ready to retire with that few dollars he has in Amgen stock. My guess is he is looking for a big payout sometime in the future. You don't go from a sure thing to a very risky opportunity unless you have knowledge & confidence in what is going to happen. Why all the job postings lately if this company is truly on the ropes and has nothing coming in terms of new investment. If the company is 60 days from Being delisted on NASDAQ do you think this guy would take the risk to join MannKind. With his credentials he could go to any other big Pharma you want to or for that matter any other public company.
|
|
|
Post by dreamboatcruise on Jan 4, 2017 15:15:58 GMT -5
What I believe would be the last possibility is that he's been planted there by Amgen in some elaborate plot to mask secret, black ops plans to subtly acquire a seriously struggling biotech by periodically sending officers over, under the auspices of being a legitimate MNKD employee mind you, to initiate a take over or transition after a buy out takes place. If Amgen wanted to buy MNKD they could do so today with a resonable offer and send Mr. Tross over as an Amgen employee to do it immediately if he really was there for Amgen all along. Would this mean Mike is involved too and has been a double agent this whole time? ? That crafy devil.... A+ for creativity but no. And Amgen may well be a front for the KGB. Mike could well be deep cover sleeper... even his kids don't know. Ok, probably just that I'm having withdrawal from having The Americans between seasons... but it's possible, right?
|
|
|
Post by dreamboatcruise on Jan 4, 2017 15:18:56 GMT -5
Well if i had pretty much 4 million in just my work stock (assuming he has at least that much in other forms of retirement) I'd hit the cash out button and get out of the rat race to a life with more sand and turquoise waters Being that Stuart is in his mid-50s I would guess he is not ready to retire with that few dollars he has in Amgen stock. My guess is he is looking for a big payout sometime in the future. You don't go from a sure thing to a very risky opportunity unless you have knowledge & confidence in what is going to happen. Why all the job postings lately if this company is truly on the ropes and has nothing coming in terms of new investment. If the company is 60 days from Being delisted on NASDAQ do you think this guy would take the risk to join MannKind. With his credentials he could go to any other big Pharma you want to or for that matter any other public company. That is a valid argument, though it would lie somewhere on a spectrum which would be hard to quantify since we have no idea about his appetite or aversion to risk. Other than the slight increase in burn, I don't see a way of interpreting this hire as a negative indicator.
|
|
|
Post by agedhippie on Jan 4, 2017 15:27:51 GMT -5
I was wondering what the deal was so I talked a a friend at Amgen. This is an Amgen press release from early November about an appointment effective Dec 9th - Amgen Appoints Lori Johnston As Senior Vice President, Human Resources. Lori was recruited externally and reports directly to the CEO. Rumor has it she was bought in to clean up the HR department. My guess is that Stuart was let go. That being the case he probably got a nice package and his options vested. In that position taking a Mannkind job makes sense - there is little downside. He has the Amgen package regardless, Mannkind are paying him well I expect, his CV still has him as the head of an HR department in a pharma. Worst case is Mannkind goes bust and he is back where he was two and a half months ago. Now this is all from reading the tea leaves and rumors but my gut feel is that it is not far from the mark. I want to add that if he was let go I don't see that as a negative. Over the years I have seen a lot of people let go and some of them were very good indeed.
|
|
|
Post by kbrion77 on Jan 4, 2017 15:35:54 GMT -5
I was wondering what the deal was so I talked a a friend at Amgen. This is an Amgen press release from early November about an appointment effective Dec 9th - Amgen Appoints Lori Johnston As Senior Vice President, Human Resources. Lori was recruited externally and reports directly to the CEO. Rumor has it she was bought in to clean up the HR department. My guess is that Stuart was let go. That being the case he probably got a nice package and his options vested. In that position taking a Mannkind job makes sense - there is little downside. He has the Amgen package regardless, Mannkind are paying him well I expect, his CV still has him as the head of an HR department in a pharma. Worst case is Mannkind goes bust and he is back where he was two and a half months ago. Now this is all from reading the tea leaves and rumors but my gut feel is that it is not far from the mark. I want to add that if he was let go I don't see that as a negative. Over the years I have seen a lot of people let go and some of them were very good indeed. Are you saying you miss Diane Palumbo..............
|
|
|
Post by sportsrancho on Jan 4, 2017 15:39:33 GMT -5
From Gary on ST. He is also going to the RLS presentation in SD and will be at the dinner in Temecula. Jan. 4 at 11:23 AM Barnstormer @jiveturkey 4,540 Not huge but encouraging Rosabel bought 9,043 2 3 Jan. 4 at 11:05 AM Barnstormer $MNKD Matt & Rosabel buying shares now I like it! Not the kind of thing you would do if you are going private 7 3 Jan. 4 at 9:15 AM Barnstormer trondisc Elop Seriously? He wasnt an HR manager and you cant compare him to Castagna Hold on to your belief if it gives you comfort 10 Jan. 4 at 8:51 AM Barnstormer @bigcheeze So they disrupt their core business to plant key executives in a spec company? Sorry BC I cant buy that. I have been through M&As 7 Jan. 4 at 8:42 AM Barnstormer @bigcheeze WS will see you hired Amgen people in the PR. No secret there. 5 Jan. 4 at 8:41 AM Barnstormer @bigcheeze What if you send them over as employees and they think the product sucks & deal doesnt happen your employees are stranded 4 Jan. 4 at 8:33 AM Barnstormer @bigcheeze You do send representatives that have signed NDAs to access if it is a fit for your company but you dont send them as emloyees. 1 5 Jan. 4 at 7:55 AM Barnstormer @rooksleanne @kevinmik Most personnel moves are at the beginning of a new year.Tross probably worked close with Mike hiring&firing sales rep 6 Jan. 4 at 7:04 AM Barnstormer
|
|
|
Post by mnkdorbust on Jan 4, 2017 16:18:34 GMT -5
Well if i had pretty much 4 million in just my work stock (assuming he has at least that much in other forms of retirement) I'd hit the cash out button and get out of the rat race to a life with more sand and turquoise waters Being that Stuart is in his mid-50s I would guess he is not ready to retire with that few dollars he has in Amgen stock. My guess is he is looking for a big payout sometime in the future. You don't go from a sure thing to a very risky opportunity unless you have knowledge & confidence in what is going to happen. Why all the job postings lately if this company is truly on the ropes and has nothing coming in terms of new investment. If the company is 60 days from Being delisted on NASDAQ do you think this guy would take the risk to join MannKind. With his credentials he could go to any other big Pharma you want to or for that matter any other public company. I'm not disagreeing with anything you said as i agree 100%. I have been and remain in this for the long haul boom or bust. Just thinking out loud via post saying my dream is to hit the cash out button someday which is one of many reasons i chose to invest in MNKD.
|
|
|
Post by sportsrancho on Jan 4, 2017 16:22:55 GMT -5
Added to Websight: Stuart A. Tross Stuart A. Tross, Ph.D. is our Chief People Officer, with responsibilities for Human Resources, Information Technology, and West Coast Facilities. Dr. Tross joins MannKind with extensive experience in the life sciences industry. From 2006 to 2016 he served in roles of increasing responsibility at Amgen, the last three years as Senior Vice President and Chief Human Resources Officer responsible for Human Resources and security on a global basis. From 1998 to 2006 he served in a series of leadership roles at Bristol-Myers Squibb, the last three years as Vice President and Global Head of Human Resources for Mead Johnson Company. Stuart received a B.S. degree from Cornell University and M.S. and Ph.D. degrees in Industrial-Organization Psychology from the Georgia Institute of Technology. MANNKIND CORPORATION www.mannkindcorp.com/stuart-a-tross/
|
|